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The antimicrobial polymer PHMB 
enters cells and selectively 
condenses bacterial chromosomes
Kantaraja Chindera1,2, Manohar Mahato3, Ashwani Kumar Sharma3, Harry Horsley4, 
Klaudia Kloc-Muniak2, Nor Fadhilah Kamaruzzaman1,5, Satish Kumar6, Alexander McFarlane7, 
Jem Stach7, Thomas Bentin8 & Liam Good1,2
To combat infection and antimicrobial resistance, it is helpful to elucidate drug mechanism(s) of action. 
Here we examined how the widely used antimicrobial polyhexamethylene biguanide (PHMB) kills 
bacteria selectively over host cells. Contrary to the accepted model of microbial membrane disruption 
by PHMB, we observed cell entry into a range of bacterial species, and treated bacteria displayed cell 
division arrest and chromosome condensation, suggesting DNA binding as an alternative antimicrobial 
mechanism. A DNA-level mechanism was confirmed by observations that PHMB formed nanoparticles 
when mixed with isolated bacterial chromosomal DNA and its effects on growth were suppressed by 
pairwise combination with the DNA binding ligand Hoechst 33258. PHMB also entered mammalian 
cells, but was trapped within endosomes and excluded from nuclei. Therefore, PHMB displays 
differential access to bacterial and mammalian cellular DNA and selectively binds and condenses 
bacterial chromosomes. Because acquired resistance to PHMB has not been reported, selective 
chromosome condensation provides an unanticipated paradigm for antimicrobial action that may not 
succumb to resistance.
The broad-spectrum antimicrobial biocide polyhexamethylene biguanide (PHMB; polyhexanide) kills bacteria, 
fungi, parasites and certain viruses with a high therapeutic index1; it is widely used in clinics, homes and industry2 
(Supplementary Table 1). It is most commonly used as a biocide, but is also an important drug used in several top-
ical applications. PHMB is composed of repeating basic biguanidine units connected by hexamethylene hydro-
carbon chains, providing a cationic and amphipathic structure. Despite extensive use over several decades, and 
efforts to identify acquired resistant mutants, resistance to PHMB has not been reported3. The evidence for a lack 
of acquired resistance is necessarily negative, and the possibility of mutation to resistance remains; nevertheless, 
it is striking that bacteria with acquired resistance have not been identified following extensive and varied usage.
The bactericidal properties of PHMB have been demonstrated against a range of species2,4, follow first order 
kinetics5 and have been observed within one hour at concentrations below 10 μg/mL4. Also, its high therapeu-
tic index has long been attributed to the polymer having comparatively less activity against mammalian mem-
branes6–10. The prevailing model for PHMB’s microbe-selective toxicity holds that PHMB disrupts microbial 
membranes preferentially. However, this model relies on data from artificial membrane studies and it does 
not explain how PHMB is able to kill diverse microbes, which differ in cell barrier composition11,12, nor does it 
explain observations that PHMB can induce DNA repair pathways13. Therefore, the literature contains conflict-
ing evidence and interpretations regarding the antibacterial mechanism of action of PHMB. When considering 
the membrane disruption model and possible alternatives, it may be important to recognize that PHMB has a 
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capacity for both electrostatic and H-bonding interactions14, which could occur at many possible targets in cells. 
For example, PHMB binding to nucleic acid has been demonstrated in vitro15, raising at least one possible alter-
native mechanism of action.
To re-examine its mechanism(s) of action, we subjected PHMB to cellular, molecular and biophysical analy-
sis, using both bacterial and mammalian cell systems. We examined its membrane activities and cellular effects 
using a PHMB-fluorophore conjugate together with cell growth, microscopy and physiological assays. Also, we 
examined PHMB/nucleic acid interactions using biophysical methods. Surprisingly, the results reveal that PHMB 
enters both bacterial and mammalian cells, condenses bacterial chromosomes and is excluded from mammalian 
nuclei. The outcome suggests a new model to explain its selective antimicrobial activities.
Results
Bacterial cell membrane activities of PHMB. If the antibacterial activity of PHMB (Fig. 1a) is due 
to membrane disruption, as widely reported6–10, it would be expected to permeabilise bacterial cell barriers at 
growth inhibitory and sub growth inhibitory concentrations. To test this model, we first established the minimal 
inhibitory concentrations (MIC) and time kill properties for PHMB against Escherichia coli (strains K-12 and 
MG1655) and Salmonella enterica serovar Typhimurium (strain LT2). As reported previously2,4, PHMB displayed 
potent growth inhibitory and cidal properties (Supplementary Table 2 and Supplementary Fig. 1). Also, following 
treatment, we examined cells using light microscopy. Unexpectedly, growth inhibitory concentrations of PHMB 
did not lyse cells, as monitored by bright-field microscopy. To assess cell barrier damage that could be invisible to 
microscopy, E. coli K-12 cultures were grown to mid-log phase, treated with PHMB in the presence of the fluores-
cent membrane integrity probe SYTOX® Green, and then monitored using fluorimetry. This probe is useful as an 
indicator of membrane damage; because it is normally excluded from intact bacteria and its fluorescence quan-
tum yield increases upon DNA binding. Therefore, intact bacteria are expected to display low fluorescence, and 
fluorescence is expected to increase following cell barrier damage16. As anticipated, freshly grown E. coli cultures 
displayed large increases in fluorescence following treatment with the known cell wall disruptor polymyxin B or 
heat treatment (Fig. 1b). Unexpectedly, PHMB treatment resulted in comparatively lower levels of fluorescence. 
Most strikingly, higher concentrations of PHMB resulted in fluorescence at background levels. These observa-
tions are not compatible with membrane disruption as the main antibacterial mechanism, and therefore raised 
further doubt about the established model.
PHMB enters bacteria. If PHMB’s primary target is not bacterial cell barriers, or not exclusively cell bar-
riers, then it likely acts internally, and this would require cell entry. To test for bacterial entry, we synthesised 
a PHMB-FITC conjugate (Supplementary Fig. 2a,b) and assessed uptake into Gram-positive (Staphylococcus 
aureus), Gram-negative (Escherichia coli and Salmonella enterica serovar Typhimurium) and acid-fast 
(Mycobacterium smegmatis) bacteria using microscopy and flow cytometry (Fig. 1c, Supplementary Fig. 3). 
Strong cell-associated green fluorescence was observed in all species tested (Fig. 1c). To examine cell localisation 
more thoroughly, the large-sized bacterium Bacillus megaterium was treated with PHMB-FITC, counter-stained 
with membrane localizing wheat germ agglutinin (WGA-red), and examined by fluorescence microscopy 
(Fig. 1d). Cell entry was observed in both live and fixed cells, and a fluorescence intensity profile analysis shows 
that PHMB-FITC localized within the cytoplasm, without accumulation at the cell barrier (Fig. 1e).
The observation that PHMB enters cells at low microgram/mL concentrations suggests that it may enter 
live cells. To investigate whether PHMB uptake into bacteria requires energy metabolism, mid-log phase 
E. coli cultures were incubated at 37 °C, or at 4 °C for 2 hours to reduce cellular ATP levels. Subsequently, cells were 
treated with PHMB-FITC (0–6 μg/ml) and further incubated on ice for 2 hours. Cell-associated PHMB-FITC 
fluorescence was quantified by fluorimetry (Supplementary Fig. 3b). Cells held at 4 °C displayed reduced 
PHMB-FITC uptake relative to cells incubated at 37 °C, consistent with an energy dependent cell uptake pro-
cess. Also, green fluorescent and motile bacteria were observed at several time points during PHMB treatment 
(Supplementary Fig. 3). Because bacterial motility is energy dependent17, the evidence indicates that PHMB-FITC 
enters metabolically active cells. Therefore, PHMB enters diverse bacteria and entry was observed in motile cells.
PHMB arrests cell division and condenses bacterial chromosomes. When examining E. coli by 
microscopy, we noted that PHMB treated cells often displayed an elongated morphology, which can be char-
acteristic of cell division inhibition (Fig. 2a). To measure the effects of PHMB on cell elongation, we titrated 
PHMB into growing cultures of E. coli strain SS996 (vide infra) and measured cell lengths. At growth inhibitory 
concentrations, more than 80% of cells elongated (Fig. 2b; Supplementary Table 2). Also, we observed that E. coli 
treated with growth inhibitory concentrations of PHMB or PHMB-FITC followed by DAPI-staining displayed 
blue fluorescent foci near the cell centre (Fig. 2c). These structures resembled nucleoids18. To ease visualisation of 
the DNA foci, we generated filamentous/multinucleated populations of E. coli by inhibiting cell division through 
RNA silencing of the essential cell division gene ftsZ19. RNA silencing was selected for this experiment because 
it enables specific and controllable repression of translation of essential gene transcripts20. Genes that are growth 
essential cannot be knocked-out by genome disruption methods, as this would result in non-viable strains. In 
the absence of PHMB, filamentous cells showed uniform DAPI staining, whereas PHMB treated cells displayed 
blue “strings of beads” (Fig. 2d). Similarly, in the large-sized Gram-positive bacteria B. megaterium we observed 
DAPI-stained foci following PHMB treatment (Fig. 2e). These results, in both Gram-negative and Gram-positive 
species, show that PHMB exposure leads to condensed chromosomes within bacteria.
PHMB-mediated antibacterial effects are independent of stress response pathways. Cell elon-
gation and chromosome condensation are characteristic morphologies that are often associated with the bacterial 
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SOS response21,22. Therefore, we considered that these effects could involve this response. However, in the case 
of PHMB-mediated effects, an SOS response seemed unlikely. First, the SOS response is typically associated 
with DNA damage and there is no evidence for PHMB-mediated genotoxic or epigenetic effects23. Second, the 
condensation observed following ftsZ silencing and PHMB treatment occurred in a recA− strain (TOP10), which 
is an SOS response mutant. Nevertheless, antimicrobial mechanisms are notoriously difficult to decipher and 
may involve multiple mechanisms. Therefore, we decided to assess the possible involvement of an SOS response 
and other stress response pathways using an SOS reporter strain and a panel of E. coli stress response pathway 
mutants.
To test whether PHMB-mediated effects on cell elongation and chromosome condensation are altered by 
mutations to the SOS response pathway, we evaluated morphological responses in three mutant E. coli strains. 
Strain SS996 is able to initiate an SOS response, but due to a sulB mutation the response does not lead to cell divi-
sion inhibition. This is because SS996 has a mutant allele of ftsZ (sulB103), the product of which is insensitive to 
the action of the SOS-induced cell division inhibitor SulA24. Strain JW2669 does not produce functional RecA, 
Figure 1. PHMB effects on cell membrane permeability and entry into bacteria. (a) Structure of 
polyhexamethylene biguanide (PHMB; CAS# 27083-27-8); alternative chemical names: polyhexanide; example 
trade names: Vantocil™ , Cosmocil™ , Baquacil™ , Prontosan® . See Supplementary Table 1 for further details. 
PHMB is composed of repeating basic biguanidine units connected by hexamethylene hydrocarbon chains, 
providing a cationic and amphipathic structure with a high capacity for hydrogen bonding, electrostatic and 
hydrophobic interactions. PHMB preparations typically comprise polymers of mixed length with amine, 
guanidine and cyanoguanidine end groups (eg. average n = 13.8, 3,035 g/mol44) (b) Effects of PHMB, heat, 
polymyxin B (positive control) and triclosan (negative control) on cell permeability to SYTOX® Green. The 
MIC values for the antibacterials tested are indicated with colour-coded vertical arrows, at top. (c) Fluorescence 
microscopy of PHMB-FITC entry into diverse bacteria. PHMB-FITC (2 μg/mL) was added to bacterial cultures 
and the cells were counter stained with DAPI. (d) Confocal image showing localisation of PHMB-FITC (green) 
in B. megaterium; bacteria were counterstained with the membrane localising probe wheat germ agglutinin 
(WGA) conjugated to Alexa Fluor-555 (red) and visualized as live (top) and fixed (bottom) cells; Bar = 5 μm. 
(e) Fluorescence intensity profile plot analysis of cellular localisation of PHMB-FITC and WGA fluorescence 
(the white line indicated the cross section used for analysis). The green line indicates the levels of FITC and 
position (mainly within the cell). The red line indicates the levels of WGA and position (mainly within the 
membrane).
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and so is SOS deficient. Strain AB2474 has a mutation in the LexA repressor that renders it non-cleavable by 
RecA, and so is not able to induce an SOS response (additional strain details are given in Fig. 3 and Supplementary 
Information Table 3). Cultures in mid-log phase were treated with PHMB, DAPI stained and observed under a 
fluorescence microscope. As observed with E. coli K-12, the mutant strains displayed elongated morphologies 
and condensed chromosomes following PHMB treatment (Fig. 3a). Therefore, PHMB-mediated cell division and 
chromosome structure effects occur independently of an SOS programmed response.
To more directly measure whether PHMB induces an SOS response, we used the E. coli strain SS996, which 
is a reporter strain that contains a sulAp-gfp chromosomal SOS response/reporter system24,25. If an SOS response 
is caused by PHMB, then PHMB exposure should induce GFP expression in this strain. Cultures of SS996 were 
treated with PHMB for 18 hours and then green fluorescence was measured. Mitomycin C, which damages DNA, 
was included as a positive control, and triclosan, which inhibits fatty acid biosynthesis, was included as a negative 
control. As expected, mitomycin C induced a large increase in GFP expression and triclosan did not induce GFP 
expression. In contrast to mitomycin C, PHMB did not induce GFP expression, indicating that PHMB does not 
induce an SOS response (Fig. 3b).
We next tested whether strains with defective or deregulated SOS responses differ in susceptibility to PHMB. 
To test recA-mediated effects on susceptibility, we used a strain of E. coli that lacks recA (JW2669) and a strain that 
overexpresses recA upon addition of the inducer IPTG (ASKA JW2669), and determined MIC values. Neither 
deletion nor induced overexpression of recA altered susceptibility to PHMB (Supplementary Information Table 3, 
rows shaded in dark grey). In contrast, the recA− strain was 2-fold more susceptible to the SOS response inducing 
Figure 2. PHMB-mediated cell elongation and chromosome condensation in bacteria. (a) E. coli was 
treated with PHMB for 90 minutes and examined by bright field microscopy. (b) Mean cell length as a function 
of PHMB concentration. MIC (arrow) is indicated. (c) Pattern of chromosome distribution in cells following 
PHMB-FITC treatment. Cultures of E. coli, strain K-12 were treated with PHMB-FITC, counter stained with 
DAPI and examined using fluorescence microscopy. Chromosomes appear as condensed DAPI-stained foci; 
more apparent in the enlarged image. (d) Pattern of chromosome distribution in filamentous/multinucleated  
E. coli following PHMB exposure. RNA silencing of ftsZ expression was used to arrest cell division, and cells 
were then untreated or treated with PHMB, stained with DAPI and examined by fluorescence microscopy. (e) 
Pattern of chromosome distribution in B. megaterium cells that were untreated or treated with PHMB, stained 
with DAPI and WGA-red and examined using fluorescence microscopy.
www.nature.com/scientificreports/
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drug nalidixic acid, and recA overexpression reduced susceptibility to nalidixic acid 8-fold. To test lexA-mediated 
effects on PHMB susceptibility, we used the lexA1(Ind−) strain AB2474, which is unable to induce an SOS 
response. Relative to the parent, AB2474 was 1-fold more susceptible to PHMB and 1-fold less susceptible to 
nalidixic acid (Supplementary Table 3, rows shaded in light grey). Therefore, none of the SOS response mutants 
tested displayed changes in susceptibility to PHMB that indicate involvement of an SOS response.
Figure 3. Effects of PHMB on bacterial SOS responses. (a) Chromosome condensation in E. coli strains SS996 
(sulB103; FtsZ mutant insensitive to SulA), JW2669 (recA−; knock-out of recA) and AB2474 (lexA1, mutation 
that prevents SOS response induction) following treatment with PHMB for 2 hours. Cells were DAPI stained 
to reveal DNA. (b) SOS response reporter expression, quantified by fluorimetry. The SOS reporter E. coli strain 
SS996 carrying a chromosomal sulAp-gfp fusion was untreated or treated with PHMB, mitomycin C, a known 
SOS inducer, or triclosan, which does not induce an SOS response. The MIC values against SS996 were PHMB, 
0.75 μg/mL; triclosan, 2 μg/mL; mitomycin C, 0.06 μg/mL, and these values were used to calculate %MIC.
www.nature.com/scientificreports/
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Finally, we considered whether other (non-SOS) stress response pathways affect susceptibility to PHMB. We 
tested a series of known E. coli stress response mutants in parallel with their parent for susceptibility to PHMB. 
None of the mutants displayed changes in MIC values that suggest a functional involvement of any of the stress 
response pathways (Supplementary Table 3). Therefore, the antibacterial effects of PHMB occur independently of 
the panel of stress response mechanisms tested.
PHMB condenses bacterial chromosomes in vitro. If PHMB condenses bacterial chromosomes inside 
cells, this could occur via direct or indirect effects on DNA. We suspected direct effects, because PHMB has 
been shown to bind to DNA fragments in vitro15. We decided to examine the DNA binding properties of PHMB 
using isolated E. coli chromosomal DNA. PHMB-DNA interactions were first examined using an electrophoretic 
mobility shift assay (EMSA) and a dye exclusion assay. PHMB was mixed with chromosomal DNA isolated from 
E. coli K-12, and the mixtures were fractionated in agarose/TBE gels, followed by DNA staining with ethidium 
bromide. PHMB:DNA mixtures having wt:wt ratios of ≥ 0.5 displayed clearly retarded electrophoretic mobility, 
as indicated by retention of DNA in the well (Fig. 4a). Similar results were obtained for PHMB-FITC. Retarded 
mobility and retention in wells is consistent with stable interactions between PHMB and DNA. Also, the EMSA 
assays indicated reduced ethidium bromide fluorescence in the presence of PHMB or PHMB-FITC, suggesting 
that ethidium bromide was prevented from binding to DNA due to formation of PHMB:DNA complexes. This 
observation was further investigated using the DNA binding dye SYTOX® Green in a dye exclusion assay. In the 
absence of PHMB, SYTOX® Green bound isolated E. coli DNA, as indicated by a large increase in fluorescence, 
relative to the addition of dye alone. However, prior addition of PHMB reduced fluorescence > 80% (Fig. 4b). 
Therefore PHMB forms complexes with bacterial DNA in a way that retards electrophoretic mobility and masks 
DNA access to DNA ligands. The results of each of these experiments indicate that PHMB binds directly to DNA.
To learn more about how PHMB binding to DNA impacts the structure of chomosomal DNA, we used bio-
physical methods and microscopy. Combinations of PHMB and isolated E. coli chromosomal DNA were exam-
ined by circular dichroism (CD) spectroscopy. PHMB alone did not show a characteristic CD spectrum, whereas 
isolated chromosomal DNA showed a typical DNA spectrum with a positive maximum ellipticity around 260 nm, 
a negative cross over at 252 nm and a negative trough at around 245 nm. This allowed us to assess changes in the 
CD spectrum of DNA following addition of PHMB. Mixtures of PHMB and DNA displayed reduced ellipticity 
at 260 nm, indicative of structural changes to the DNA upon PHMB binding (Fig. 4c,d). Also, dynamic light 
scattering (DLS) revealed that PHMB binding to DNA results in the formation of nanoparticles of approximately 
50–60 nm, with a low polydispersity index (Supplementary Fig. 4a). Finally, transmission electron microscopy 
Figure 4. PHMB binding to bacterial chromosomal DNA in vitro. (a) PHMB or PHMB-FITC was mixed 
with isolated chromosomal DNA from E. coli strain K-12, and samples were analysed by EMSA. Patterns of 
retarded in-gel mobility indicate DNA binding by PHMB. (b) PHMB-mediated exclusion of SYTOX® Green 
binding to isolated E. coli chromosomal DNA, where reduced fluorescence indicates DNA binding by PHMB. 
(c) Circular dichroism spectroscopy of mixtures of PHMB and isolated E. coli chromosomal DNA. (d) Plot of 
ellipticity as a function of PHMB:DNA ratios.
www.nature.com/scientificreports/
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(TEM) and fluorescence microscopy also indicated that PHMB binding to DNA results in the formation of nan-
oparticles (Supplementary Fig. 4b,c). Therefore, these results confirm earlier reports that PHMB binds DNA26, 
and reveals that PHMB binds isolated bacterial chromosomal DNA and can condense chromosomes into a low 
polydispersity population of nanoparticles.
The antibacterial effects of PHMB are suppressed by a dsDNA ligand. Our results for PHMB 
effects on bacteria cannot be reconciled with the membrane disruption model for PHMB’s primary antibacterial 
mechanism of action. Rather we propose a new model, where PHMB enters bacteria and then condenses chro-
mosomes, as illustrated in Fig. 5a. If correct, the new model would also predict functional interactions between 
PHMB and other DNA ligands, and this idea provided us with a way to test the model. In brief, if this model were 
correct, small molecular weight DNA ligands would be expected to suppress PHMB’s antibacterial potency by 
competing for DNA binding sites within chromosomes. To test this possibility, pairwise combinations of PHMB 
and Hoechst 33258 were used in growth susceptibility assays. Hoechst 33258 is a DNA ligand that binds prefer-
entially to the minor groove of AT-rich sequences27 and it is cell-permeable, making it a suitable choice for this 
competition experiment.
Drug interactions were calculated as fractional inhibitory concentration index values (FICI) using a panel 
of diverged bacterial species. The FICI values for PHMB:Hoechst were significantly higher than for PHMB 
combined with either of two non-DNA ligand antibacterials (Fig. 5b). Also, the FICI values for PHMB:Hoechst 
combinations show a positive correlation with chromosome AT-content (Fig. 5c). In other words, PHMB’s anti-
microbial effects depend on access to DNA inside cells. In B. megaterium, the effects of PHMB:Hoechst combi-
nations were striking, where growth inhibition by PHMB was suppressed using subinhibitory Hoeschst 33258 
concentrations (Fig. 5d). Therefore, the small molecule DNA ligand Hoechst 33258 rescued bacteria from inhib-
itory concentrations of PHMB.
These pairwise drug interactions reveal that the antibacterial effects of PHMB occur mainly via targeting 
DNA in bacteria. Consistent with the cell permeability change profile observed for PHMB (Fig. 1b); the results 
also indicate competition between PHMB and a DNA ligand for DNA binding sites inside cells. Therefore, the 
results from separate experiments involving two known DNA ligands are consistent with our new model for 
PHMB activity.
PHMB enters mammalian cells but is excluded from nuclei. The prevailing model for PHMB activ-
ity holds that PHMB kills bacteria through bacterial membrane damage and the polymer does not interact 
with mammalian cell membranes (see above). However, given the unexpected bacterial cell entry properties of 
Figure 5. Model for the antibacterial mechanism of action of PHMB, and suppression of growth inhibition. 
(a) Proposed antibacterial mechanism of action of PHMB. (b) Pairwise growth inhibition interactions between 
PHMB and Hoechst 33258 and negative control non-DNA-binding ligands (triclosan and trimethoprim) in 
diverse bacterial species. (c) Relationship between bacterial genome AT-content and antibacterial interactions 
with PHMB. Plot of growth inhibition interactions and DNA AT-content in diverse species. Interaction values 
are fractional inhibitory concentration indicies (FICI) between PHMB and Hoechst 33258 or negative control 
non-DNA-binding ligands (trimethoprim and triclosan). (d) Bacillus megaterium growth inhibition by PHMB 
and suppression by combinations with the DNA ligand Hoechst 33258 (blue lines). See Supplementary Table 4 
for species list and inhibition values.
www.nature.com/scientificreports/
8Scientific RepoRts | 6:23121 | DOI: 10.1038/srep23121
PHMB, and our recent observations that PHMB enters cultured macrophage28 and keratinocytes29, we decided 
to directly assess its ability to enter a panel of mammalian cells. PHMB-FITC was added to several mammalian 
cell lines and primary fibroblasts and uptake was assessed by fluorescence microscopy and flow cytometry. We 
observed clear uptake into all cell types tested (Fig. 6a,b). Also, these conditions did not lead to disruption of 
mammalian cell membrane integrity (Supplementary Fig. 5a). Close inspection of the microscopy images reveals 
that PHMB-FITC was contained within vesicles and excluded from nuclei (Fig. 6a). If it is true that endosomes 
entrap PHMB, then release into the cytoplasm should de-quench PHMB-FITC and lead to an increase in fluores-
cence. This is because FITC fluorescence is quenched at low pH and the late endosomal pH is < 630, whereas the 
cytoplasmic pH is 7.4. We observed that the addition of chloroquine, an osmolytic/buffering agent31, increased 
the fluorescence of PHMB-FITC treated cells (Fig. 6c), consistent with polymer entrapment within endosomes. 
Therefore, PHMB efficiently enters mammalian cells, but is entrapped within endosomes, which appears to 
restrict entry into nuclei.
Discussion
The arsenal of registered antimicrobial agents (antibiotics + biocides) exploits only a small number of defined 
mechanisms32. Past studies on the mechanism of action of PHMB focused on its ability to interact with micro-
bial membranes in preference to mammalian membranes. The present study, in contrast, suggests an alternative 
model. The results demonstrate that PHMB is able to enter bacterial cells, arrest cell division and condense chro-
mosomes, resulting in intracellular foci of DNA. PHMB is revealed as the first example of a drug that binds and 
condenses bacterial chromosomes. Indeed, this is the first example of any drug that condenses chromosomes.
Chromosome condensation has not previously been considered as an antibacterial mechanism of action; how-
ever, the feasibility of using a cationic polymer to directly condense chromosomes in bacteria is suggested by 
several prior findings: (i) the regulation of bacterial DNA condensation and decondensation appears to involve 
polyamine and basic protein binding33, (ii) condensation aids chromosome partitioning during cell division34, 
(iii) overexpression of histone-like proteins leads to nucleoid condensation and bacterial cell death35,36, (vi) chro-
mosomes in bacterial cell lysates are condensed by the addition of polylysine37, and (v) certain cationic polymers 
enter bacteria38,39. Therefore, while indirect mechanisms leading to chromosome condensation in bacteria remain 
formally possible, our data indicates a direct mechanism, where PHMB binds and condenses DNA following cell 
entry (Fig. 5a), and the prior evidence outlined above is consistent with this new model.
A chromosome condensation model for the antibacterial action of PHMB (Fig. 5a) can explain how PHMB 
kills bacteria, but also raises a new and difficult question. How can chromosome condensation provide a selective 
antibacterial mechanism, given that all organisms have chromosomes? In other words, if PHMB enters cells and 
condenses bacterial chromosomes, why doesn’t it also kill mammalian cells and display toxic effects when used 
in clinical applications? The data shown in Fig. 6 provide an answer by showing that PHMB’s distribution within 
mammalian cells is partitioned. Specifically, it localizes within endosomes and is excluded from nuclei. Therefore, 
PHMB’s antibacterial selectivity appears to involve differential target access through drug partitioning inside cells, 
rather than by the well-established principles of target recognition and structure conservation40.
Mammalian cell uptake and nuclear exclusion of PHMB are unexpected observations; however, they may 
reflect aspects of how mammalian cells evolved together with microbes. For example, cationic antimicrobial 
peptides are central to innate immunity, and our observations may indicate mechanisms that protect host cells 
against endogenous cationic antimicrobial peptides and other natural molecules that could bind cellular DNA. 
Also, these observations raise interesting questions about potential toxicity and how PHMB kills eukaryotic path-
ogens. Recently, we reported that PHMB is able to enter the parasite Leishmaniasis major, and following parasite 
cell entry, PHMB disrupts chromosomes within nuclei28. Therefore, we have observed similar mechanisms in 
both bacteria and parasites, suggesting that chromosome condensation or disruption appears to be a major mech-
anism of action of PHMB that is effective against diverse pathogens. Understanding antimicrobial mechanisms 
can aid further drug development41. We hope that the results of this study will inspire antimicrobial strategies 
designed to selectively condense microbial chromosomes - a mechanism that does not appear to succumb to 
acquired resistance3.
Materials and Methods
Synthesis of PHMB–FITC conjugates. Polyhexamethylene biguanide (PHMB) was from Arch Chemicals 
(UK) and Tecrea Ltd, (UK). Fluorescein isothiocyanate (FITC, 2 mg, Sigma-Aldrich, UK) was dissolved in 800 μl 
dimethyl formamide (Sigma-Aldrich, UK), containing 50 μl of N,N-diisopropylethylamine (Sigma-Aldrich, UK). 
The mixture was combined with 200 μl aqueous PHMB (50 mg), and shaken overnight at room temperature. The 
resulting solution was dialyzed using a molecular weight cut off membrane 3.5 kDa against 50% aqueous ethanol 
for 5 days with intermittent change of dialysate (10 times, 500 mL), lyophilised to obtain fluoresceinyl-PHMB 
(PHMB-FITC) and characterized by infrared spectroscopy, IR (Nujol), ν (cm−1): 756 cm−1 (C = S stretching).
Determination of Minimal Inhibitory Concentrations (MIC), Minimal Bactericidal 
Concentrations (MBC) and Fractional Inhibitory Concentration Index (FICI). All E. coli strains, 
S. enterica serovar Typhimurium LT2 and S. aureus NCTC 6571 were grown in Mueller Hinton broth (MHB, 
Fluka, Germany) at 37 °C overnight. Where required, MHB was supplemented with kanamycin or chloramphen-
icol/IPTG (Supplementary Table 3). MICs were determined by serial dilution of the antibacterial in 200 μl MHB 
containing 105 colony forming units (CFU)/mL using 96-well plates (Costar, UK). Plates were incubated for 
18 hours at 37 °C in a BioTek Power-Wave X340I spectrophotometer with shaking for 5 seconds every 5 minutes 
followed by recording of the absorbance at 550 nm. The MIC was scored as the lowest concentration of compound 
at which no growth was observed. To determine the minimal bactericidal concentration (MBC; > 103 CFU/mL 
reduction), bacterial cultures at 105 CFU/mL were treated or not treated with PHMB and at specific time points 
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samples were diluted and plated on LB agar plates. CFUs were counted after 18 hours of incubation at 37 °C. FICIs 
were determined using the checkerboard assay as described 42, using Hoechst 33258 (Sigma-Aldrich, UK).
Figure 6. PHMB entry into mammalian cells. (a) Primary fibroblasts were treated with PHMB-FITC (3.5  
μg/mL), counter stained with Hoechst 33258 and observed by fluorescence microscopy. (b) Flow cytometry 
analysis of a panel of mammalian cells treated with PHMB-FITC. Inset: a representative example of a flow 
cytometry histogram of HeLa cell populations that were untreated (purple population) or treated with 
PHMB-FITC (0.4 μg/mL) (green population). (c) HeLa cells were treated with PHMB-FITC (3.5 μg/mL) 
and chloroquine (0–20 μM) for 2 hours. The effects of chloroquine on fluorescence were measured by flow 
cytometry, using geometric mean fluorescence intensity (arbitrary units (A.U.), log scale).
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Bacteria cell membrane permeability assay. E. coli K-12 from mid log phase (10 μl of culture, OD600 
adjusted to 0.1) were transferred to 96-well plates containing PHMB, polymyxin B or triclosan (0–8 μg/mL) in 
100 μl phosphate buffered saline (PBS), and incubated at 37 °C for 60 minutes in a BioTek Power-Wave X340I 
spectrophotometer with shaking for 5 seconds every 5 minutes. To generate cells with maximum permeability 
to SYTOX® Green, untreated cultures were incubated for 10 minutes in a heating block maintained at 70 °C. The 
dye SYTOX® Green (Invitrogen, UK) was added to a final concentration of 1 μM, and changes in fluorescence 
emission were monitored at 535 nm upon excitation at 485 nm using a Wallac Victor 1420 Multi label counter 
(PerkinElmer, UK). SYTOX® Green fluoresces strongly upon binding to DNA, and fluorescence was taken as an 
indication of membrane permeabilisation43.
Epi-fluorescence microscopy of bacteria and particles. Overnight bacterial cultures of E. coli K-12, 
SSPP6 and JW2669-1, S. enterica serovar Typhimurium LT2, and S. aureus NCTC 6571 were diluted 1:50 in 
MHB and incubated for 2 hours to reach mid log phase. M. smegmatis MC2155 was grown in Middlebrook 7H9 
broth with 10% OADC enrichment (BD Biosciences, UK) for 18 hours. Aliquots from mid log phase cultures 
were diluted in MHB (E. coli and S. enterica) or 7H9 broth (M. smegmatis) to 0.1 OD600, and 100 μl aliquots were 
transferred to 1.5 mL tubes, PHMB-FITC (0–8 μg/mL) was added and the cultures were incubated for 90 minutes. 
Following incubation, bacteria were washed 3 times using 200 μl 1× PBS via centrifugation at 5000 rpm for 5 min-
ute and removal of the supernatants. Bacteria pellets were resuspended in 100 μl of 1 μM DAPI (Invitrogen, UK) 
in 1× PBS and incubated at room temperature for 10 minutes, then mounted on a glass slide and observed under 
a fluorescence microscope (Leica DM4000B microscope with Zeiss “AxioVision” software).
For particle analyses, PHMB:DNA mixtures were prepared as described above for the dye exclusion assay and 
loaded on an agarose bed (1.5% in 1× PBS) prepared on a glass slide, overlaid with a glass coverslip and observed 
under an upright fluorescence microscope using a FITC filter set (400× magnification, Leica DM4000B micro-
scope, “AxioVision” software).
Electrophoretic mobility shift assay (EMSA). Chromosomal DNA from overnight cultures of E. coli 
K-12 was isolated using GenElute™ bacterial chromosomal DNA isolation Kit (Sigma-Aldrich, UK) according to 
the manufacturer’s instructions. Mixtures of isolated chromosomal DNA and PHMB were prepared by titrating 
0.5 μg of chromosomal DNA with PHMB (0–0.75 μg) in a final volume of 50 μl 1× PBS followed by incubation at 
37 °C for 30 minutes. The resulting samples were combined with 6× Blue/Orange loading dye (Promega, UK) and 
analyzed by electrophoresis using 0.8% agarose gels containing ethidium bromide.
Circular dichroism (CD) spectroscopy. CD spectra of E. coli DNA (0.1 mg/mL) from E. coli K-12 were 
recorded from 190 to 320 nm in 10 mM phosphate buffer, pH 7.0 at 25 °C in a CD spectropolarimeter (JASCO, 
J-810 model, Japan) using a 0.1 cm path length cuvette. Six scans (20 nm/minute) were taken and the results were 
averaged. PHMB:DNA interactions were monitored by titrating isolated chromosomal DNA (150 μl, 100 μg/mL) 
with PHMB (0.0025–100 μg/mL, final volume). A CD spectrum base line correction was made for each PHMB 
concentration. Structural changes in DNA were monitored by plotting ellipticity at 260 nm (θ 260) against PHMB 
concentration. The experiments were repeated three times.
Dye exclusion assay. PHMB (0–4 μg/mL, final) and isolated chromosomal DNA from E. coli K-12 (1 μg/mL, 
final) were mixed in 100 μl 1× PBS in a 96-well plate and incubated at 37 °C for 30 minutes. Following incubation, 
SYTOX® Green was added to 100 nM, and the plates were further incubated for 10 minutes at 37 °C and fluores-
cence was measured as described in the bacteria cell membrane permeability assay; see above.
Confocal microscopy of bacteria. To explore the spatial distribution of PHMB in live bacteria, one of the 
largest known Gram positive bacteria, B. megaterium, was exposed to PHMB-FITC and counterstained with a 
fluorescent membrane marker. B. megaterium was cultured in LB broth overnight before dilution to 108 CFU/mL 
in fresh broth containing a final concentration of 5 μg/mL of PHMB-FITC. Following incubation in a shaker for 
120 minutes at 37 °C, the bacteria were washed and stained with DAPI as described above. Bacterial pellets were 
re-suspended in 1× PBS and 80 μl of the suspension was centrifuged in a Shandon Cytospin 2 cytocentrifuge at 
800 rpm (75 × g) for 5 minutes before circumscribing the slide-deposited bacteria with a hydrophobic barrier pen 
(ImmEdge pen, Vector Laboratories). Cells were fixed in 4% formaldehyde (Thermo Scientific, Fisher Scientific) 
in 1× PBS at room temperature for 15 minutes. The formaldehyde was aspirated and the preparation were washed 
three times with 1× PBS at 5 minute intervals. To label the bacterial cell membrane, the fixed bacteria were 
immersed in 100 μl of Hank’s balanced salt solution (HBSS) minus phenol red (Invitrogen) containing 5 μg/mL 
wheat germ agglutinin (WGA) conjugated to Alexa Fluor-555 (Invitrogen). Following 20 minute incubation at 
room temperature, the labeling solution was removed and the slides were washed twice at 5 minute intervals with 
fresh HBSS. The preparation was mounted with FluorSave reagent (Calbiochem) and a coverslip fixed in place 
with clear nail varnish. Slides were kept at − 20 °C. Laser scanning confocal microscopy was conducted using a 
Leica SP5 microscope (Leica Application Suite, Advanced Fluorescence 3.1.0 build 8587 Software). Sequential 
scan Z-stacks (115 slice 1024 × 1024) were compiled at a line average of 96. ImageJ 1.49r was used to produce, 
analyse and profile plot dual channel composite Z-stacks.
Generation of filamented bacteria. Overnight cultures of E. coli TOP 10 carrying a plasmid expressing 
lac promoter driven antisense RNA against bacterial cell division ftsZ mRNA (anti-ftsZ) were grown in MHB 
for 18 hours in the presence of chloramphenicol (30 μg/mL, Sigma-Aldrich, UK) to maintain the plasmid19. 
Overnight cultures were diluted 50-fold in MHB and IPTG (75 μm) was added to induce anti-ftsZ expression. 
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Cultures were further incubated for 90 minutes in an orbital shaker at 37 °C in the presence or absence of PHMB. 
Following incubation, bacteria were washed and stained with DAPI as described above and observed under a 
fluorescence microscope (630× magnification, Leica DM4000B microscope, Zeiss “AxioVision” software).
SOS response assay. Overnight cultures of E. coli strain SS996 (105 CFU/mL) were sub-cultured in the 
absence or presence of PHMB, mitomycin C (Roche, UK) or triclosan (Ciba AG, Switzerland) in MHB for 
18 hours in a 96-well plate in a Bio-Tek PowerWave X340I spectrophotometer as described above, and SOS 
response was assessed as described previously25. GFP expression was measured in a Wallac Victor2 1420 Multi 
label counter using 485 nm (excitation) and 535 nm (emission).
Dynamic light scattering. PHMB:DNA mixtures (25 μg/mL:10 μg/mL) were diluted with 900 μl of 0.2 μm 
filtered water and mean particle size was measured by dynamic light scattering in a Zetasizer Nano ZS instrument 
(Malvern instruments, UK). Mean size represents the average of 20 readings. Experiments were repeated inde-
pendently three times.
Transmission electron microscopy. PHMB:DNA (25 μg/mL:10 μg/mL) mixtures were loaded onto car-
bon coated copper grids, stained with aqueous 1% uranyl acetate for 30 seconds, air dried and visualised under 
a transmission electron microscope operated at 200 kV and 6500× magnification (Tecnai G2 30 U-twin, USA). 
Corresponding concentrations of PHMB alone were used as control.
Mammalian cell culture. HeLa, HEK 293, MDBK, equine primary fibroblasts, Saos-2, CHO, and J774.A1 
cells were maintained in DMEM (Invitrogen) with 10% FBS (Invitrogen), Penicillin (100 units/mL, Invitrogen) 
and streptomycin (100 μg/mL, Invitrogen). THP-1 monocytes were maintained in RPMI 1640 medium with 10% 
FBS. To sub-culture adherent cells, the growth medium was removed and cells were washed twice with Hank’s 
buffered salt solution (Invitrogen, UK). To detach cells, 2 mL of 0.05% trypsin - EDTA (Invitrogen, UK) was 
added and the cells were incubated at 37 °C for 5 minutes. Detached cells were counted using 0.4% Trypan blue 
(Invitrogen, UK) and the cells were seeded into 12 well tissue culture plates (0.1 × 106 cells/well) and 75 cm2 tissue 
culture flask.
Epi-fluorescence microscopy of mammalian cells. Equine primary fibroblasts were grown to ∼60% 
confluence and treated with PHMB-FITC (0–4 μg/mL) or free FITC (0.389 μg /mL; 1 μM) in DMEM and 
incubated for 2 hours. Following incubation, nuclei were stained using 1 μM Hoechst 33342 (Invitrogen, UK) 
in DMEM by incubating cells at 37 °C for 30 minutes. Following nuclear staining, cells were washed 3 times 
with PBS, and the extracellular fluorescence was quenched with 0.04% trypan blue (Invitrogen, UK) in ice cold 
1× PBS for 10 minutes. Cells were washed twice with 1× PBS, mounted on glass slides with aqueous fluoromount 
(Sigma-Aldrich, UK) and observed under a fluorescence microscope (Leica DM4000B, “AxioVision” software). 
PHMB-FITC uptake was scored by flow cytometry using an FL1 filter set (FACSCaliburTM, CellQuest™ software, 
BD Bioscience). Similarly, PHMB uptake was assessed in other adherent cell lines (HEK 293, MDBK, Saos-2, 
CHO and J774.A1). To investigate uptake into suspension cells, 5 × 105 THP-1 monocytes were transferred to a 
96-well plate containing PHMB-FITC (0–4 μg/mL) in a final volume of 100 μl RPMI 1640 and incubated at 37 °C 
for 2 hours. Following incubation, cells were rinsed twice with 1× PBS and cellular uptake was quantified by flow 
cytometry. Free FITC (1 μM) and untreated cells were used as negative controls to set background fluorescence.
Flow cytometry. Cell associated fluorescence of PHMB-FITC treated or untreated cells was analysed by flow 
cytometry (FACSCaliburTM; CellQuest™ software, BD Bioscience) using an FL1 filter set. Adherent mammalian 
cells were trypsinised and diluted to 106 cells/mL prior to flow cytometry. Untreated cells were used to establish 
thresholds for gating fluorescence negative cells. Results were analysed using Flowjo7.6.5 software.
Propidium idodide (PI) mammalian cell membrane integrity assay. To assess membrane perme-
ability, HeLa cells were grown in 12-well plates and treated with PHMB (0–4 μg/mL) in DMEM for 2 hours. 
Following incubation, cells were rinsed twice with 1× PBS and treated with propidium iodide (PI, 2 μg/mL, 
Sigma-Aldrich, UK), for 15 minutes, PI uptake was analysed by flow cytometry.
Endosome release assay. PHMB-FITC (3.5 μg/mL) was suspended in 1× PBS solutions in the pH range 
4.06–7.4 (pH adjusted with 0.1 M HCl). The solutions were incubated at room temperature for 10 minutes and 
fluorescence was measured by recording emission at 535 nm upon excitation at 485 nm in a fluorimeter. HeLa 
cells were co-treated with 3.5 μg/mL PHMB-FITC and chloroquine (0–150 μM, Sigma-Aldrich, UK) for 2 hours at 
37 °C and fluorescence was quantified by flow cytometry. The number of cells positive for uptake and the geomet-
ric mean (GM) was recorded to assess the cell-associated fluorescence from three independent experiments.
Data analysis. Data are represented as mean ± standard deviation from at least three independent experi-
ments. Data in Fig. 5 and Supplementary Fig. 5 were analysed by one-way ANOVA and data in Supplementary 
Fig. 2 were analysed by two-way ANOVA, followed by Tukey’s Post test (Prism 6, GraphPad, Inc., San Diego, CA). 
P < 0.05 was considered as statistically significant (*).
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